Skip to content
← Index board

Health Optimization Index

Oxytocin (Intranasal)

Nick’s assessment
Promising
Research evidence
C, mixed evidence
Attention
4.7 / 100▼ Falling this week
6.5/ 10

BioHarmony score

Intranasal oxytocin is the endogenous bonding hormone used off-label as a nasal spray for social connection, anxiety, and libido. It is exceptionally safe, with no reliable side effects across 38 trials per MacDonald 2011, but the marketed brain effects are inconsistent: the largest autism RCT in 290 children was null per Sikich 2021.

Read the full report Benefits, risks and practical guidance.

Read Nick’s assessment Why it earned this rating

It pairs an outstanding safety record with genuinely inconsistent efficacy for the very uses it is marketed for. If you are curious, even-keeled, and want a low-risk, low-cost acute experiment for connection or social ease in a specific moment, it is a reasonable thing to try, provided you can source clean compounded material and go in expecting a subtle or possibly absent effect. If you are looking for a reliable, evidence-backed treatment for autism, anxiety, or low libido, the honest read is that the best evidence does not support it: the largest therapeutic trial was null, per Sikich 2021, and the founding trust finding did not replicate, per Nave 2015. Think of it as real but oversold, and very safe to test.

✅ Best for: Curious, even-keeled people who want a one-off experiment for connection or social ease before a date, event, or hard conversation. People who can source clean compounded oxytocin rather than a sketchy grey-market vial. Those who accept the brain delivery is slow and dose 45 to 75 minutes ahead. Anyone who will judge it honestly on their own response over a few tries, since the non-response group is large. People drawn to its endogenous nature and clean safety record who want the lowest-risk entry point into social-peptide experimentation.

❌ Avoid if: You expect a reliable love drug or a guaranteed mood lift, because the marketed effects are inconsistent and the famous trust finding failed to replicate, per Nave 2015. You are treating autism and want evidence-backed help, since the largest trial was null, per Sikich 2021. You want a dependable libido tool, where the melanocortin pathway behind PT-141 has more direct data. You cannot verify source quality, because peptide purity and potency vary widely and a degraded vial does nothing. You are inclined to use it daily, given the unquantified desensitization question and the lack of any cumulative benefit.

Share your experience

Your answers are optional and help other readers — they never change my score. How community input works.

Tried it in real life?

How would you assess it?

Favorable is the strongest rating, followed by Promising, then Experimental. Overhyped means the claims outrun the evidence or interest is fading.

Make a 12-month prediction Will it rise or fall in the Index?

Choose a direction and your confidence. Correct predictions earn leaderboard points.

Your 12-month call on Oxytocin (Intranasal)
How sure are you?

Your prediction is final once submitted. We’ll check it in 12 months. See the leaderboard →

Updated Sep 21, 2026 How the Index ranks →

Educational information, not medical advice. Ask a qualified clinician about risks and interactions. Independent ratings: no affiliate links, sponsored placements or paid rankings.